PULM - Pulmatrix Quarterly EPS earnings growth

Symbol and logo of brand Pulmatrix Corp (PULM)

Pulmatrix, Inc. (PULM) is resilient to market volatility, as its success depends on trial phases. The current quarterly EPS growth rate allows for the tracking of this trend, while the 32.70 metric indicates the efficiency status. The asset is not subject to seasonality, as it develops lung inhalers. Developments based on iSPERSE target the fight against fungal infections and COPD.

Pulmatrix (PULM) Year-over-year earnings per one share growth for the last 12 months: for the period 07/04/2022 - 11/12/2026

PULM (Pulmatrix Corporation): analytical breakdowns and indicator data

- share price and expert price forecast:
Stock Price Pulmatrix|PULM - Fair Value Consensus
- market capitalization statistics:
Market Capitalization Pulmatrix Corp|PULM - Total Enterprise Value
- balance sheet net asset value indicators:
Net Assets per Single Share Pulmatrix|PULM - Accounting Value of Company|Market Value to Book Value Ratio pulmatrix.com|PULM - Total Asset Value of Company
- company liabilities and liquidity data:
Total Debt to Equity Ratio Pulmatrix, Inc.|PULM - Long-Term Debt to Capital|Short-Term Debt to Equity Pulmatrix, Inc.|PULM - Company Debts|Debt to Book Capitalization Ratio Pulmatrix Corp|PULM - Company Long-Term Liabilities|Company Short-Term Debts Pulmatrix|Quick Liquidity Indicator pulmatrix.com
- earnings and market multiples details:
PULM - Profit After Payment of Taxes|Expected Profit Pulmatrix, Inc.|PULM - Company Value to Net Income|Forward P/E Multiple Pulmatrix Corp|PULM - Growth-Adjusted Market Cap to Net Income|Enterprise Value to EBITDA Ratio Pulmatrix Corp|PULM - Operating profit before amortization|Net earnings per share for the last 12 months Pulmatrix|PULM - Earnings per share for the trailing year|Quarterly EPS earnings growth pulmatrix.com|PULM - Expected net earnings per share growth this year|Net earnings per share growth forecast for next year Pulmatrix, Inc.
Fundamental valuation:Pulmatrix, Inc.
Finished products of Pulmatrix, Inc.

This indicator measures the year-over-year dynamics of net earnings per share on a quarterly basis, allowing for an assessment of capital management efficiency and business scaling rates. By analyzing the quarterly EPS comparison, an investor can identify the operational resilience of Pulmatrix, Inc. (PULM), which is critical given the company's high dependence on the clinical trial results of its highly specialized portfolio of inhalation drugs.

Main competitors

HLN: Quarterly EPS earnings growth|Kenvue Inc - Year-over-year earnings per one share growth for the last 12 months|VRNA (Verona Pharma Corp) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Jyong Bio MENS|Year-over-year earnings per share growth for the last twelve months Ligand Pharmaceuticals (LGND)|AMRX (amneal.com) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Perrigo PRGO|ALVO (Alvotech S.A.) - Year-over-year net earnings per share trend for the last twelve months|LQDA: Year-over-year net earnings per share growth for the last 12 months|GLPG - Quarterly EPS earnings growth|ANI Pharmaceuticals (ANIP) - Year-over-year earnings per share growth for the last twelve months|MNKD (mannkindcorp.com) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last twelve months Amphastar Pharmaceuticals, Inc.|Year-over-year net earnings per share growth for the last 12 months Pacira Pharmaceuticals (PCRX)|Quarterly EPS earnings growth SPRY|Quarterly EPS earnings growth Theravance Corp (TBPH)|Aquestive Therapeutics - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months SCPH (scPharmaceuticals, Inc.)|TECX - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per one share growth for the last 12 months TNXP (Tonix Pharma)|SXTC: Quarterly EPS earnings growth|EPRX - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months BHST|Year-over-year earnings per share growth for the last 12 months EXOZ (invizyne.com)|Year-over-year net earnings per share growth for the last 12 months ORMP (Oramed Pharmaceuticals)|ENTX (enterabio.com) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth HYFT (MindWalk)|Year-over-year net earnings per share change for the last twelve months ABVC BioPharma, Inc (ABVC)|CPIX - Year-over-year earnings per share growth for the last twelve months|QNTM (quantumbiopharma.com) - Year-over-year earnings per share growth for the last 12 months|FGEN: Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Telomir Pharmaceuticals Inc|Year-over-year net earnings per share growth for the last 12 months RANI|Synergy CHC Corporation (SNYR) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Rallybio Corporation (RLYB)|LEXX: Year-over-year net earnings per share trend for the last twelve months|Pheton Holdings - Year-over-year net earnings per share growth for the last 12 months|Quarterly EPS earnings growth Aptorum Group Ltd APM|LYRA - Year-over-year earnings per share growth for the last twelve months|IBO: Year-over-year earnings per share growth for the last twelve months|tnfpharma.com (TNFA) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months cbdMD|Year-over-year earnings per share growth for the last twelve months PainReform|Auris Medical - Year-over-year net earnings per share trend for the last twelve months|Quarterly EPS earnings growth LIPO|OPTN (OptiNose Corp) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth PIRS (Pieris Pharmaceuticals)|Quarterly EPS earnings growth procapsgroup.com PROC|PTPI - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per one share growth for the last 12 months QLI (Qilian International Holding Group)|ACELYRIN, Inc. (SLRN) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months TFF Pharmaceuticals, Inc